Massive Bio – Artificial Intelligence Machine Learning – Next Digital Health nextdigitalhealth.com

Massive Bio is a New York-based tech-enabled big-data platform that leverages the power of artificial intelligence and big data to enable cancer patients to access treatment options. Founded in 2015 by a diverse team consisting of technology, clinical, and M&A executives, the company also helps pharmaceutical companies optimize drug development and commercialization. Massive Bio has a global presence with about 100 people in 12 countries.